Trinity Biotech (TRIB) Reports Q4 Loss of $0.23/sh

Trinity Biotech (NASDAQ: TRIB) reported Q4 EPS of ($0.23), versus $0.60 reported last year. Revenue for the quarter came in at $19.5 million versus the consensus estimate of $22 million.

For earnings history and earnings-related data on Trinity Biotech (TRIB) click here.

You May Also Be Interested In

• Trinity Biotech’s Trinovium Subsidiary Agrees to Collaborate with Echelon Data Centres to Develop Advanced Liquid Cooling Solutions for AI Infrastructure
• Jasper Therapeutics (JSPR) Tops Q2 EPS by 18c
• Smith-Midland Corporation (SMID) Tops Q2 EPS by 26c